EDGAR Filing Documents for 0000885590-12-000070

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000885590-12-000070

Filing Date

2012-11-05

Accepted

2012-11-05 16:51:16

Documents

Period of Report

2012-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	valeantq32012.htm	10-Q	2623817
2	EXHIBIT 10.1	exhibit101.htm	EX-10.1	111058
3	EXHIBIT 10.4	exhibit104.htm	EX-10.4	551420
4	EXHIBIT 10.5	exhibit105.htm	EX-10.5	177777
5	EXHIBIT 10.6	exhibit106.htm	EX-10.6	170310
6	EXHIBIT 10.8	exhibit108.htm	EX-10.8	65244
7	EXHIBIT 31.1	exhibit311-q32012.htm	EX-31.1	14686
8	EXHIBIT 31.2	exhibit312-q32012.htm	EX-31.2	14640
9	EXHIBIT 32.1	exhibit321-q32012.htm	EX-32.1	8568
10	EXHIBIT 32.2	exhibit322-q32012.htm	EX-32.2	8550
	Complete submission text file	0000885590-12-000070.txt		25527627

Data Files

Seq	Description	Document	Type	Size
11	EXHIBIT-101.INS	vrx-20120930.xml	EX-101.INS	3884280
12	EXHIBIT-101.SCH	vrx-20120930.xsd	EX-101.SCH	214305
13	EXHIBIT-101.CAL	vrx-20120930_cal.xml	EX-101.CAL	119444
14	EXHIBIT-101.LAB	vrx-20120930_lab.xml	EX-101.LAB	3131547
15	EXHIBIT-101.PRE	vrx-20120930_pre.xml	EX-101.PRE	1588581
16	EXHIBIT-101.DEF	vrx-20120930_def.xml	EX-101.DEF	1268165

Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9

Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)